POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864 | +96.2% | 783,071 | +45.0% | 0.00% | +200.0% |
| Q2 2023 | $950 | -48.9% | 540,024 | -10.5% | 0.00% | -50.0% |
| Q1 2023 | $1,858 | +78.7% | 603,200 | +207.3% | 0.00% | +100.0% |
| Q4 2022 | $1,040 | -99.9% | 196,300 | -42.8% | 0.00% | -50.0% |
| Q3 2022 | $1,212,000 | +23.5% | 343,300 | -9.7% | 0.00% | +100.0% |
| Q2 2022 | $981,000 | +17.1% | 380,100 | +103.3% | 0.00% | 0.0% |
| Q1 2022 | $838,000 | +265.9% | 187,000 | +456.5% | 0.00% | – |
| Q4 2021 | $229,000 | +143.6% | 33,600 | +160.5% | 0.00% | – |
| Q3 2021 | $94,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
| Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
| Knott David M Jr | 140,921 | $248 | 0.10% |
| XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
| Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
| Atom Investors LP | 49,413 | $86,967 | 0.03% |
| EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
| Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
| FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |